Treating eye disease with gene therapy with Jasleen Jolly MCOptom

In the first episode of 2020, Martin and Daniel introduce Jasleen Kaur Jolly MCOptom, optometrist and researcher working at the Nuffield Laboratory of Ophthalmology and Wellcome Integrative Neuroimaging centre, University of Oxford, and Oxford Eye Hospital. Jasleen talks to Martin about how she got into research, imposter syndrome, how gene therapy works, which conditions are closer to being treated with gene therapy and what that means for optometrists, as well as the brain and the eye. Jasleen is involved in clinical research in the fields of retinal gene therapy, surgery outcomes and low vision. She is currently finishing a National Institute of Health Research funded PhD and also won the College's highly prestigious Philip Cole Prize for practice-based research in 2018.

There are no comments yet.

Please log in to write the first comment.